Eye retention after proton beam radiotherapy for uveal melanoma

被引:190
作者
Egger, E [1 ]
Zografos, L
Schalenbourg, A
Beati, D
Böhringer, T
Chamot, L
Goitein, G
机构
[1] Paul Scherrer Inst, Div Radiat Med, CH-5232 Villigen, Switzerland
[2] Hop Ophtalm Jules Gonin, Lausanne, Switzerland
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2003年 / 55卷 / 04期
关键词
uveal melanoma; proton therapy; eye retention; treatment outcome;
D O I
10.1016/S0360-3016(02)04200-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To analyze the long-term results of eye retention after conservative treatment of uveal melanoma with proton beam radiotherapy, and to analyze the causes leading to enucleation after this conservative treatment approach. Methods and Materials: This was a prospective, noncomparative, interventional, consecutive case series. A total of 2645 patients (2648 eyes) with uveal melanoma were treated between 1984 and 1999 with proton beam radiotherapy. Data were analyzed as of February 2001. Patients' age ranged from 9 to 90 years, 1284 were men, and 1361 were women. Largest tumor diameter ranged from 4 to 27.5 mm, and tumor height from 0.9 to 15.6 mm. Median follow-up time was 44 months. Results: The overall eye retention rate at 5, 10, and 15 years after treatment was 88.9%, 86.2%, and 83.7%, respectively. In total, 218 eyes had to be enucleated. Enucleation was related to larger tumor size, mainly tumor height, proximity of posterior tumor margin to optic disc, male gender, high intraocular pressure, and large degree of retinal detachment at treatment time. After optimization of the treatment technique, the eye retention rate at 5 years was increased from 97.1% to 100% for small tumors, from 86.7% to 99.7% for medium, and from 71.1% to 89.5% for large tumors. Conclusions: The treatment technique-as used today results in excellent eye retention rates, even in less favorable cases such as large tumors and tumors located close to the optic disc. The experience and a continuous quality control program allowed us to improve the 5-year eye retention rate for all tumor sizes. These findings demonstrate the positive impact of experience and quality control-based efforts for treatment technique optimization. (C) 2003 Elsevier Science Inc.
引用
收藏
页码:867 / 880
页数:14
相关论文
共 20 条
[1]   Ten-year follow-up of helium ion therapy for uveal melanoma [J].
Char, DH ;
Kroll, SM ;
Castro, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 125 (01) :81-89
[2]   Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma [J].
Daftari, IK ;
Char, DH ;
Verhey, LJ ;
Castro, JR ;
Petti, PL ;
Meecham, WJ ;
Kroll, S ;
Blakely, EA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (05) :997-1010
[3]   Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma [J].
Egger, E ;
Schalenbourg, A ;
Zografos, L ;
Bercher, L ;
Boehringer, T ;
Chamot, L ;
Goitein, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01) :138-147
[4]  
EGGER E, 1993, PROTON BEAM IRRADIAT, P57
[5]   TREATMENT OF CHOROIDAL MELANOMA WITH I-125 PLAQUE [J].
FONTANESI, J ;
MEYER, D ;
XU, SZ ;
TAI, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (04) :619-623
[6]  
GRAGOUDAS ES, 1980, OPHTHALMOLOGY, V87, P571
[7]   PROTON IRRADIATION OF SMALL CHOROIDAL MALIGNANT MELANOMAS [J].
GRAGOUDAS, ES ;
GOITEIN, M ;
KOEHLER, AM ;
VERHEY, L ;
TEPPER, J ;
SUIT, HD ;
BROCKHURST, R ;
CONSTABLE, IJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1977, 83 (05) :665-673
[8]   Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement [J].
Gündüz, K ;
Shields, CL ;
Shields, JA ;
Cater, J ;
Freire, JE ;
Brady, LW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 127 (05) :579-589
[9]  
Gündüz K, 1999, ARCH OPHTHALMOL-CHIC, V117, P170
[10]   The treatment of choroidal melanoma with 198Au plaque brachytherapy [J].
Karvat, A ;
Duzenli, C ;
Ma, R ;
Paton, K ;
Pickles, T .
RADIOTHERAPY AND ONCOLOGY, 2001, 59 (02) :153-156